Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

Þorvarður R. Hálfdánarson, Kari G. Rabe, Joseph Rubin, +1

Annals of Oncology

Treatment of the Malignant Carcinoid Syndrome

Larry K. Kvols, Charles G. Moertel, Michael J. O’Connell, +3

New England Journal of Medicine

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms

Charles G. Moertel, Larry K. Kvols, Michael J. O’Connell, +1

Cancer

Tumor ResponseNeuro-oncologyEndocrine OncologyCombined EtoposideMedicine +11

Surgical Treatment of Neuroendocrine Metastases to the Liver

Juan M. Sarmiento, Glenroy Heywood, Joseph Rubin, +3

Journal of the American College of Surgeons

Percutaneous Image-Guided Radiofrequency Ablation of Painful Metastases Involving Bone: A Multicenter Study

Matthew P. Goetz, Matthew R. Callstrom, J. William Charboneau, +17

Journal of Clinical Oncology

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

M. J. OʼConnell, John A. Laurie, Michael Kahn, +11

Journal of Clinical Oncology

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Keith C. Bible, Vera J. Suman, Julian R. Molina, +16

The Lancet Oncology

Thyroid CancersOncologyMedicineThyroid DiseaseConsortium Study +9

Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome

Joseph Rubin, Jaffer A. Ajani, William J. Schirmer, +6

Journal of Clinical Oncology

Painful Metastases Involving Bone: Feasibility of Percutaneous CT- and US-guided Radio-frequency Ablation

Matthew R. Callstrom, J. William Charboneau, Matthew P. Goetz, +12

Radiology

Percutaneous image‐guided cryoablation of painful metastases involving bone

Matthew R. Callstrom, Damian E. Dupuy, Stephen B. Solomon, +13

Cancer